255 related articles for article (PubMed ID: 8971788)
1. Identification of advanced glycation end products of the Maillard reaction in Pick's disease.
Kimura T; Ikeda K; Takamatsu J; Miyata T; Sobue G; Miyakawa T; Horiuchi S
Neurosci Lett; 1996 Nov; 219(2):95-8. PubMed ID: 8971788
[TBL] [Abstract][Full Text] [Related]
2. Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains.
Kimura T; Takamatsu J; Miyata T; Miyakawa T; Horiuchi S
Pathol Int; 1998 Aug; 48(8):575-9. PubMed ID: 9736403
[TBL] [Abstract][Full Text] [Related]
3. Involvement of clathrin light chains in the pathology of Pick's disease; implication for impairment of axonal transport.
Nakamura Y; Takeda M; Yoshimi K; Hattori H; Hariguchi S; Hashimoto S; Nishimura T
Neurosci Lett; 1994 Oct; 180(1):25-8. PubMed ID: 7533277
[TBL] [Abstract][Full Text] [Related]
4. Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith MA; Taneda S; Richey PL; Miyata S; Yan SD; Stern D; Sayre LM; Monnier VM; Perry G
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5710-4. PubMed ID: 8202552
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain.
Jono T; Kimura T; Takamatsu J; Nagai R; Miyazaki K; Yuzuriha T; Kitamura T; Horiuchi S
Pathol Int; 2002 Sep; 52(9):563-71. PubMed ID: 12406185
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons.
Kimura T; Takamatsu J; Ikeda K; Kondo A; Miyakawa T; Horiuchi S
Neurosci Lett; 1996 Apr; 208(1):53-6. PubMed ID: 8731173
[TBL] [Abstract][Full Text] [Related]
7. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
8. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical and ultrastructural studies of Pick's disease.
Murayama S; Mori H; Ihara Y; Tomonaga M
Ann Neurol; 1990 Apr; 27(4):394-405. PubMed ID: 2162145
[TBL] [Abstract][Full Text] [Related]
10. Filaments of Pick's bodies contain altered cytoskeletal elements.
Perry G; Stewart D; Friedman R; Manetto V; Autilio-Gambetti L; Gambetti P
Am J Pathol; 1987 Jun; 127(3):559-68. PubMed ID: 3296772
[TBL] [Abstract][Full Text] [Related]
11. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease.
Muntané G; Dalfó E; Martínez A; Rey MJ; Avila J; Pérez M; Portero M; Pamplona R; Ayala V; Ferrer I
J Neurochem; 2006 Oct; 99(1):177-85. PubMed ID: 16987245
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
13. [Pick's disease. A special type of pathological aging of the brain].
Seitelberger F
Aktuelle Gerontol; 1982 Nov; 12(6):200-5. PubMed ID: 6130712
[TBL] [Abstract][Full Text] [Related]
14. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.
Litvan I; Agid Y; Sastry N; Jankovic J; Wenning GK; Goetz CG; Verny M; Brandel JP; Jellinger K; Chaudhuri KR; McKee A; Lai EC; Pearce RK; Bartko JJ
Neurology; 1997 Jul; 49(1):62-9. PubMed ID: 9222171
[TBL] [Abstract][Full Text] [Related]
15. Lobar atrophy without Pick bodies.
Hulette CM; Crain BJ
Clin Neuropathol; 1992; 11(3):151-6. PubMed ID: 1611728
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end-products in diabetic nephropathy.
Sugiyama S; Miyata T; Horie K; Iida Y; Tsuyuki M; Tanaka H; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 5():91-4. PubMed ID: 9044316
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end-products in anterior chamber aqueous of cataractous patients.
Franke S; Stein F; Dawczynski J; Blum M; Kubetschka U; Stein G; Strobel J
J Cataract Refract Surg; 2003 Feb; 29(2):329-35. PubMed ID: 12648645
[TBL] [Abstract][Full Text] [Related]
18. The Maillard reaction and food allergies: is there a link?
Toda M; Heilmann M; Ilchmann A; Vieths S
Clin Chem Lab Med; 2014 Jan; 52(1):61-7. PubMed ID: 23492561
[TBL] [Abstract][Full Text] [Related]
19. A case of Pick's disease with unusual neuronal inclusions.
Yokoo H; Oyama T; Hirato J; Sasaki A; Nakazato Y
Acta Neuropathol; 1994; 88(3):267-72. PubMed ID: 7528965
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood.
Tsukahara H; Ohta N; Sato S; Hiraoka M; Shukunami K; Uchiyama M; Kawakami H; Sekine K; Mayumi M
Free Radic Res; 2004 Jul; 38(7):691-5. PubMed ID: 15453634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
